• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Canakinumab for recurrent rheumatic disease associated-pericarditis: a case series with long-term follow-up.

作者信息

Kougkas Nikolaos, Fanouriakis Antonis, Papalopoulos Ioannis, Bertsias George, Avgoustidis Nestor, Repa Argyro, Sidiropoulos Prodromos

机构信息

Department of Rheumatology, Clinical Immunology and Allergy, University Hospital of Heraklion, Greece.

出版信息

Rheumatology (Oxford). 2018 Aug 1;57(8):1494-1495. doi: 10.1093/rheumatology/key077.

DOI:10.1093/rheumatology/key077
PMID:30060102
Abstract
摘要

相似文献

1
Canakinumab for recurrent rheumatic disease associated-pericarditis: a case series with long-term follow-up.卡那单抗治疗复发性风湿性疾病相关性心包炎：一项长期随访的病例系列研究
Rheumatology (Oxford). 2018 Aug 1;57(8):1494-1495. doi: 10.1093/rheumatology/key077.
2
Anaphylactic reaction to anakinra in a child with steroid-dependent idiopathic recurrent pericarditis and successful management with canakinumab.一名患有类固醇依赖型特发性复发性心包炎的儿童对阿那白滞素发生过敏反应，使用卡那单抗成功治疗。
Cardiol Young. 2019 Apr;29(4):549-551. doi: 10.1017/S1047951119000672. Epub 2019 Apr 1.
3
A case of rheumatoid pericarditis associated with a high IL-6 titer in the pericardial fluid and tocilizumab treatment.一例类风湿性心包炎伴心包液中高 IL-6 滴度和托珠单抗治疗。
Mod Rheumatol. 2011 Jun;21(3):302-4. doi: 10.1007/s10165-010-0377-4. Epub 2010 Nov 23.
4
Successful treatment of idiopathic recurrent pericarditis in children with interleukin-1beta receptor antagonist (anakinra): an unrecognized autoinflammatory disease?白细胞介素-1β受体拮抗剂（阿那白滞素）成功治疗儿童特发性复发性心包炎：一种未被认识的自身炎症性疾病？
Arthritis Rheum. 2009 Jan;60(1):264-8. doi: 10.1002/art.24174.
5
Long-term outcomes in difficult-to-treat patients with recurrent pericarditis.复发性心包炎难治性患者的长期预后
Am J Cardiol. 2006 Jul 15;98(2):267-71. doi: 10.1016/j.amjcard.2006.01.086. Epub 2006 Jun 5.
6
[Myopericarditis in rheumatic disease].[风湿性疾病中的心肌心包炎]
Vojnosanit Pregl. 1976 Mar-Apr;33(2):102-5.
7
Sustained efficacy of the monoclonal anti-interleukin-1 beta antibody canakinumab in a 9-month trial in Schnitzler's syndrome.在 Schnitzler 综合征的 9 个月试验中，单克隆抗白细胞介素-1β抗体 canakinumab 持续有效。
Ann Rheum Dis. 2013 Oct;72(10):1634-8. doi: 10.1136/annrheumdis-2012-202192. Epub 2012 Oct 19.
8
PERICARDIAL FEATURES OF IN-HOSPITAL RHEUMATOLOGY PATIENTS: AN OBSERVATIONAL STUDY.
Reumatizam. 2016;63(2):21-5.
9
Recurrent pericarditis in children and adolescents: a multicentre cohort study.儿童和青少年复发性心包炎：一项多中心队列研究。
J Cardiovasc Med (Hagerstown). 2016 Sep;17(9):707-12. doi: 10.2459/JCM.0000000000000300.
10
[Acute pericarditis. Study of 50 consecutive cases].
Nouv Presse Med. 1975 Nov 22;4(40):2853-7.

引用本文的文献

1
Current Drug Treatment for Acute and Recurrent Pericarditis.急性和复发性心包炎的当前药物治疗
Drugs. 2025 May;85(5):643-658. doi: 10.1007/s40265-025-02169-x. Epub 2025 Mar 22.
2
Anakinra-Dependent Recurrent Pericarditis: The Role of the R202Q Variant of the MEFV Gene.阿那白滞素依赖的复发性心包炎：MEFV基因R202Q变异体的作用
J Clin Med. 2024 Oct 11;13(20):6051. doi: 10.3390/jcm13206051.
3
Novel Treatments in Refractory Recurrent Pericarditis.难治性复发性心包炎的新型治疗方法
Pharmaceuticals (Basel). 2024 Aug 15;17(8):1069. doi: 10.3390/ph17081069.
4
Novel Pathophysiological, Diagnostic and Therapeutic Concepts in Acute and Recurrent Pericarditis.急性和复发性心包炎的新型病理生理、诊断和治疗概念
Rev Cardiovasc Med. 2023 Mar 3;24(3):77. doi: 10.31083/j.rcm2403077. eCollection 2023 Mar.
5
Interleukin-1 Blockers: A Paradigm Shift in the Treatment of Recurrent Pericarditis.白细胞介素-1阻滞剂：复发性心包炎治疗的范式转变。
Life (Basel). 2024 Feb 26;14(3):305. doi: 10.3390/life14030305.
6
Comprehensive bioinformatics analysis and systems biology approaches to identify the interplay between COVID-19 and pericarditis.综合生物信息学分析和系统生物学方法鉴定 COVID-19 与心包炎之间的相互作用。
Front Immunol. 2024 Feb 22;15:1264856. doi: 10.3389/fimmu.2024.1264856. eCollection 2024.
7
Interleukin-1 Blockers in Recurrent and Acute Pericarditis: State of the Art and Future Directions.白细胞介素-1 阻滞剂在复发性和急性心包炎中的应用：现状和未来方向。
Medicina (Kaunas). 2024 Jan 30;60(2):241. doi: 10.3390/medicina60020241.
8
Evaluation and Management of Pericarditis in Rheumatic Diseases.风湿性疾病性心包炎的评估和管理。
J Cardiovasc Pharmacol. 2024 Jun 1;83(6):491-502. doi: 10.1097/FJC.0000000000001494.
9
Paradigm Shift in Diagnosis and Targeted Therapy in Recurrent Pericarditis.复发性心包炎的诊断和靶向治疗的范式转变。
Curr Cardiol Rep. 2023 Sep;25(9):993-1000. doi: 10.1007/s11886-023-01912-8. Epub 2023 Jul 17.
10
Management of Recurrent Pregnancy-Related Pericarditis.复发性妊娠相关性心包炎的管理
Case Rep Cardiol. 2022 Mar 22;2022:5791307. doi: 10.1155/2022/5791307. eCollection 2022.